Nabriva Therapeutics (NBRVF) Q3 2018 Earnings

6NovExpected
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-0.9
-0.7
-0.49
-0.29

Details

Expected EPS
-0.29
Actual EPS
-0.9
Surprise EPS
-0.61
Surprise Percent
+210.34%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.9 per share for Q3 2018.

0 Comments

Share your thoughts